Aptose Announces Proposed Public Offering of Common Shares

NEXT STORY
Roche and Spark Therapeutics, Inc. announce closing of investigation and unconditional clearance by the FTC and expiration of Hart-Scott-Rodino waiting period for acquisition of Spark Therapeutics, Inc
PREV STORY
Forty Seven, Inc. Announces Closing of Underwritten Public Offering and Exercise in Full of Option to Purchase Additional Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

BioSig Technologies, Inc. Achieves Important Milestone

Minneapolis, MN, Aug. 11, 2016 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device ...

author_avatar
NASDAQ Market News

Loxo Oncology to Announce Second Quarter 2018 Financial Results

STAMFORD, Conn., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Immune Design Announces Launch of Web Portal for SYNOVATE Phase 3 Study of CMB305 Immunotherapy in Synovial Sarcoma

          -- 1st global Phase 3 trial focused on synovial ...

author_avatar
NASDAQ Market News